128 related articles for article (PubMed ID: 2571386)
1. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.
Davis MJ; Dawes PT; Beswick E; Lewin IV; Stanworth DR
Br J Rheumatol; 1989 Oct; 28(5):410-3. PubMed ID: 2571386
[TBL] [Abstract][Full Text] [Related]
2. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.
Taylor HG; Beswick EJ; Dawes PT
Clin Rheumatol; 1991 Mar; 10(1):43-8. PubMed ID: 1676621
[TBL] [Abstract][Full Text] [Related]
3. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
Dougados M; Boumier P; Amor B
Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
[TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine in ankylosing spondylitis.
Feltelius N; Hällgren R
Ann Rheum Dis; 1986 May; 45(5):396-9. PubMed ID: 2872857
[TBL] [Abstract][Full Text] [Related]
5. [Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies].
Schmidt WA; Wierth S; Milleck D; Droste U; Gromnica-Ihle E
Z Rheumatol; 2002 Apr; 61(2):159-67. PubMed ID: 12056293
[TBL] [Abstract][Full Text] [Related]
6. [Sulfasalazine therapy in spondylarthritis ankylopoietica].
Winkler V
Orv Hetil; 1989 Jan; 130(2):77-81. PubMed ID: 2563308
[TBL] [Abstract][Full Text] [Related]
7. [Sulfasalazine in the treatment of ankylosing spondylitis].
Krajnc I
Lijec Vjesn; 1990; 112(5-6):171-4. PubMed ID: 1978212
[TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial.
Nissilä M; Lehtinen K; Leirisalo-Repo M; Luukkainen R; Mutru O; Yli-Kerttula U
Arthritis Rheum; 1988 Sep; 31(9):1111-6. PubMed ID: 2901839
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect.
Corkill MM; Jobanputra P; Gibson T; Macfarlane DG
Br J Rheumatol; 1990 Feb; 29(1):41-5. PubMed ID: 1968354
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.
Nissilä M; Lahesmaa R; Leirisalo-Repo M; Lehtinen K; Toivanen P; Granfors K
J Rheumatol; 1994 Nov; 21(11):2082-7. PubMed ID: 7869314
[TBL] [Abstract][Full Text] [Related]
11. Increased jejunal secretory IgA and IgM in ankylosing spondylitis: normalization after treatment with sulfasalazine.
Feltelius N; Hvatum M; Brandtzaeg P; Knutson L; Hällgren R
J Rheumatol; 1994 Nov; 21(11):2076-81. PubMed ID: 7869313
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of sulphasalazine in ankylosing spondylitis--an interventional study.
Fraser SM; Sturrock RD
Br J Rheumatol; 1990 Feb; 29(1):37-9. PubMed ID: 1968353
[TBL] [Abstract][Full Text] [Related]
13. IgA-alpha 1 antitrypsin complexes in ankylosing spondylitis.
Struthers GR; Lewin IV; Stanworth DR
Ann Rheum Dis; 1989 Jan; 48(1):30-4. PubMed ID: 2784305
[TBL] [Abstract][Full Text] [Related]
14. Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.
Feltelius N; Gudmundsson S; Wennersten L; Sjöberg O; Hällgren R; Klareskog L
Ann Rheum Dis; 1991 Jun; 50(6):369-71. PubMed ID: 1676256
[TBL] [Abstract][Full Text] [Related]
15. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
Hendrix S; Koenig A; Li W; Singh A
J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
[TBL] [Abstract][Full Text] [Related]
16. Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R
Ann Rheum Dis; 1988 Jan; 47(1):10-4. PubMed ID: 2894204
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
van der Heijde D; Braun J; Dougados M; Sieper J; Pedersen R; Szumski A; Koenig AS
Rheumatology (Oxford); 2012 Oct; 51(10):1894-905. PubMed ID: 22772319
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity of alpha-1-antitrypsin bound to human IgA.
Musiani P; Lauriola L; Piantelli M
Clin Chim Acta; 1978 Apr; 85(1):61-6. PubMed ID: 417880
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
[TBL] [Abstract][Full Text] [Related]
20. No signs of Campylobacter jejuni/coli-related antibodies in patients with active ankylosing spondylitis.
Andreasen JJ; Ringsdal VS; Helin P
APMIS; 1991 Aug; 99(8):735-8. PubMed ID: 1677583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
